Correlation Between Terns Pharmaceuticals and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Protagonist Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Protagonist Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Protagonist Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Terns and Protagonist is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Protagonist Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Protagonist Therapeutics. In addition to that, Terns Pharmaceuticals is 1.83 times more volatile than Protagonist Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Protagonist Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest 4,160 in Protagonist Therapeutics on August 26, 2024 and sell it today you would earn a total of 486.00 from holding Protagonist Therapeutics or generate 11.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Protagonist Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Protagonist Therapeutics |
Terns Pharmaceuticals and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Protagonist Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
| Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |